Tobback E, Degroote S, Buysse S, Delesie L, et al. Efficacy and safety of camostat mesylate in early Covid-19 disease in an
ambulatory setting: A randomized placebo-controlled phase II trial. Int J Infect Dis 2022 Jul 5. pii: S1201-9712(22)00388.
PMID: 35803469